Pharmaceutical and Pharmacological Approaches to Improving Drug Efficacy and Safety: Current Advances, Challenges, and Future Perspectives
Journal of Pharma and Biomedics · 30.10.2026 · 4 (4) · 525-536
DOI: 10.56810/jpbm.004.04.0316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharma and Biomedics, online erschienen am 30.10.2026. Verfasst von Fatemeh Moshtaghian Abarghouei und 4 weiteren Autor:innen.
Abstract (Originalsprache)
The central aim of pharmaceutical science and clinical pharmacology is the optimization of drug efficacy with minimal drug-associated harm. Therapeutic outcomes will depend on the interactions among drug physiochemical properties, formulation, drug absorption and distribution, metabolism and elimination, target engagement, dosage, disease characteristics, and patient-specific factors. Lack of aqueous solubility, limited permeability, poor penetration of tissues, rapid clearance, off-target activity, drug interactions, and inter-individual variability may negatively affect treatment efficacy and/or toxicity. The pharmaceutical strategies focus on increasing the stability of the drug, its exposure, its delivery to the target sites, modified release, and prodrugs. Pharmacological options to support treatment selection and optimization are complementary, such as pharmacokinetic/pharmacodynamic (PK/PD) modelling, therapeutic drug monitoring, pharmacogenomics, individual dosing, rational combination therapy and systematic medication review. Pharmacovigilance also aids in the identification, evaluation, and ongoing prevention of medicines-related risks throughout a medicine's life cycle. New strategies such as synthetic artificial intelligence (AI), physiologically based pharmacokinetic modelling, organ-on-chip platforms, and model-informed precision dosing have the potential to further enhance prediction and individualize treatment but require model validation, the quality of implementation, and patient benefit to be demonstrated. An overview of the existing and current pharmaceutical and pharmacological strategies is provided with a focus on their mechanism, applications, limitations, and translational needs. The difference between formulation improvements and surrogate endpoints is highlighted, and clinically significant improvements in efficacy, safety, and QoL are emphasized. Combining pharmaceutical innovation with evidence-informed pharmacologic decision-making, comprehensive safety monitoring, and effective access might be better suited to achieve effective therapeutic outcomes that optimize use.
Zitieren
APA
Abarghouei, F. M., Alavidehkordi, M., Ozma, M., Darbandi, M. H., & Rezaeiazghand, S. (2026). Pharmaceutical and Pharmacological Approaches to Improving Drug Efficacy and Safety: Current Advances, Challenges, and Future Perspectives. Journal of Pharma and Biomedics, 4(4), 525-536. https://doi.org/10.56810/jpbm.004.04.0316
Vancouver
Abarghouei FM, Alavidehkordi M, Ozma M, Darbandi MH, Rezaeiazghand S. Pharmaceutical and Pharmacological Approaches to Improving Drug Efficacy and Safety: Current Advances, Challenges, and Future Perspectives. Journal of Pharma and Biomedics. 2026;4(4):525-536. doi:10.56810/jpbm.004.04.0316
BibTeX
@article{Abarghouei2026,
author = {Abarghouei, Fatemeh Moshtaghian and Alavidehkordi, Mahtabosadat and Ozma, Moniba and Darbandi, Mahdiyeh Heidari and Rezaeiazghand, Sara},
title = {Pharmaceutical and Pharmacological Approaches to Improving Drug Efficacy and Safety: Current Advances, Challenges, and Future Perspectives},
journal = {Journal of Pharma and Biomedics},
year = {2026},
volume = {4},
number = {4},
pages = {525--536},
doi = {10.56810/jpbm.004.04.0316}
}
EUVIMED